Isradipine
4 NDCs across 2 manufacturers|4 Generic,0 Brand
Isradipine is used to treat variant angina pectoris and hypertension, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 20, 1990, and the first generic was approved Jan 5, 2006. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $1 million on Isradipine across 6,306 claims for 1,637 beneficiaries.
Isradipine is available as 4 NDCs from 2 manufacturers (4 generic, 0 brand), with NADAC prices from $1.14 to $1.70 per EA — a 50% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
4G / 0B
Manufacturers
2
competing in market
Price Spread
$1.14 – $1.70
per EA
7d Activity
avg +0.3% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Dihydropyridine Calcium Channel Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing ISRADIPINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ISRADIPINE 5 MG CAPSULE | $1.7024 per EA | +2.57% |
ISRADIPINE 5 MG CAPSULE | $1.7024 per EA | +2.57% |
ISRADIPINE 2.5 MG CAPSULE | $1.1368 per EA | -1.91% |
ISRADIPINE 2.5 MG CAPSULE | $1.1368 per EA | -1.91% |
Frequently Asked Questions
What is Isradipine used to treat?
Isradipine is used to treat variant angina pectoris and hypertension, per the National Library of Medicine's MED-RT classification.
When did Isradipine become available as a generic?
FDA approved the first generic Isradipine (ANDA) on Jan 5, 2006. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Isradipine?
In 2024, Medicare Part D spent $1 million on Isradipine across 6,306 claims for 1,637 beneficiaries.
How many Isradipine products are on the market?
The Isradipine drug market contains 4 NDCs from 2 manufacturers — 4 generic and 0 brand products.
What is the price range for Isradipine?
NADAC reference prices for Isradipine range from $1.1368 to $1.7024 per EA — a 50% difference between cheapest and most expensive.
Which manufacturers make Isradipine?
2 manufacturers list Isradipine in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (2), Elite Laboratories, Inc. (2).
How has the price of Isradipine changed recently?
Over the past 7 days, 2 Isradipine NDCs rose and 2 fell, with a market-wide average change of +0.3%.